CVS Group plc, a leading provider of integrated veterinary services in the UK, has announced that certain employees have exercised options under the CVS Group 2022 SAYE Plan. This exercise resulted in the issuance of 4 new ordinary shares of 0.2 pence each. The admission of these new shares has been satisfied by the company's block listing on the London Stock Exchange. Following this issuance, CVS Group now has a total issued share capital of 71,429,759 ordinary shares, each carrying one voting right. The company does not hold any ordinary shares in treasury, resulting in a total number of voting rights of 71,429,759.
Shareholders can use this figure as the denominator for calculating their notification requirements under the FCA's Disclosure Guidance and Transparency Rules. CVS Group plc can be contacted through Richard Fairman, CEO, and Scott Morrison, Company Secretary. Peel Hunt LLP and Berenberg are the company's nominated adviser, broker, and joint broker, respectively. Camarco is the company's financial PR contact.
CVS Group plc operates veterinary practices in the UK, Australia, the Netherlands, and the Republic of Ireland. The company is focused on providing high-quality clinical services to its clients and their animals. It has approximately 500 veterinary practices, including specialist referral hospitals and out-of-hours sites. CVS Group also operates laboratories, crematoria, buying groups, and an online retail business called "Animed Direct."